Use of E-health Based Exercise Intervention After COVID-19

NCT05770505 | Completed

• 1 other identifier: 479316
• Study Type: interventional
• Target: 77
• Locations: 1 country
• Sites: 1

Brief Summary

Reduced subjective and objective functional capacity performance are reported after COVID-19 in a large proportion of subjects. The aim of this study is to examine the feasibility and effect of using an e-health tool for guidance and tracking of exercise training in a general population of adults previously infected by COVID-19.

Conditions

COVID-19

Outcome Measures

Primary Outcomes (2)

• Cardiorespiratory fitness

  Peak oxygen uptake

  After 6 months intervention

• Feasibilty

  Measured as acceptability and adherence

  After 6 months intervention

Secondary Outcomes (2)

• Lung function

  After 6 months intervention

• Quality of life

  After 6 months intervention

Study Arms (2)

Supervised exercise

EXPERIMENTAL

Behavioral: Exercise training using an e-health tool

Control group

NO INTERVENTION

Interventions

Exercise training using an e-health tool BEHAVIORAL

Experimental: Exercise training will be guided by using the e-health tool MIA Health, with the possibility for digital communication between the participants and study personnel The participants will receive wearables that record heart rate. Participants will be encouraged to achieve 100 Activity Quotient (AQ) equivalents per week Control: No follow-up

Supervised exercise

Eligibility Criteria

• Age: 18 Years - 59 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Persons who have undergone COVID-19 disease
• People who struggle to be physically active enough as a result of corona disease
• People who experience reduced physical fitness as a result of corona disease

You may not qualify if:

• \-- more than 100 AQ per week (calculated from self-reported activity level)
• uncontrolled hypertension (high blood pressure) (over 200/110).
• symptomatic valve failure, hypertrophic cardiomyopathy, unstable angina, pulmonary
• hypertension, heart failure and/or severe rhythm disturbances
• cancer that makes participation impossible or exercise contraindicated. Considered individually in consultation with the attending physician.
• chronic contagious infectious diseases.
• Participates in other studies that are not compatible with participation in this project
• Post-exertional symptom exacerbation (PESE)/post-exertional malaise (PEM)/post-exertional neuroimmune exhaustion (PENE).

Sponsors & Collaborators

• Norwegian University of Science and Technology: lead
• University of Oslo: collaborator

Study Sites (1)

Norwegian University of Science and Technology, Faculty of medicine, Department of circulation and medical imaging,

Trondheim, 7006, Norway

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Dorthe Stensvold Stensvold

  Dorthe Stensvold, Professor, NTNU

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 13, 2023
• First Posted: March 15, 2023
• Study Start: April 17, 2023
• Primary Completion: May 31, 2024
• Study Completion: December 31, 2024
• Last Updated: January 5, 2026

Record last verified: 2025-12

Locations

NO (1)